Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis
- PMID: 12371127
- DOI: 10.14670/HH-17.1005
Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis
Abstract
Involvement of granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) in non-lymphohematopoietic malignant tumors accompanied by leukocytosis was clinicopathologically investigated. Among 1,778 autopsy cases in the last 20 years, 485 lesions of 439 cases with non-lymphohematopoietic malignant tumors accompanied by leukocytosis with a white blood cell count of 10,000/mm3 or greater during the course were immunohistologically examined for G-CSF and GM-CSF. Three (0.7%) and two cases (0.5%) were G-CSF- and GM-CSF-positive, respectively. GM-CSF mRNA was confirmed by using non-fixed cryopreserved tumor tissues in one case positive for GM-CSF. G-CSF-positive cases were large cell carcinoma of the lung, adenocarcinoma of the colon, and adenocarcinoma of the stomach, and GM-CSF-positive cases were spindle cell carcinoma of the lung and malignant thymoma. In the case with stomach carcinoma, the primary lesion showing moderately differentiated adenocarcinoma was negative, but the lung metastatic lesion showing less differentiated adenocarcinoma was G-CSF-positive. The survival period was six months or less in four out of five positive cases. The highest white blood cell count in five CSF-positive cases was markedly elevated: 29,400-103,500/mm3 (mean: 59,700/mm3). In four cases, excluding one case which may have been markedly affected by chemotherapy, the bone marrow showed hyperplasia, and the number of the granulocyte series cells significantly increased. There were three cases (0.7%) negative for both G-CSF and GM-CSF, although they showed marked leukocytosis (60,000/mm3 or higher) which were higher than the mean count of CSF-positive cases and was not observed in autopsy cases with non-tumorous diseases. Other stimulating factors may be involved in the development of leukocytosis in such cases.
Similar articles
-
Production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by carcinomas in a dog and a cat with paraneoplastic leukocytosis.J Vet Intern Med. 1996 Nov-Dec;10(6):405-8. doi: 10.1111/j.1939-1676.1996.tb02088.x. J Vet Intern Med. 1996. PMID: 8947874
-
A high-fat diet increases interleukin-3 and granulocyte colony-stimulating factor production by bone marrow cells and triggers bone marrow hyperplasia and neutrophilia in Wistar rats.Exp Biol Med (Maywood). 2013 Apr;238(4):375-84. doi: 10.1177/1535370213477976. Exp Biol Med (Maywood). 2013. PMID: 23760003
-
Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.Int J Cancer. 2004 May 10;109(6):826-32. doi: 10.1002/ijc.20023. Int J Cancer. 2004. PMID: 15027115
-
Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma.Jpn J Clin Oncol. 1998 Sep;28(9):559-62. doi: 10.1093/jjco/28.9.559. Jpn J Clin Oncol. 1998. PMID: 9793030 Review.
-
The effect of granulocyte and granulocyte-macrophage colony stimulating factors on tumor promotion.J BUON. 2017 Jan-Feb;22(1):21-28. J BUON. 2017. PMID: 28365931 Review.
Cited by
-
Prognostic Model of Eleven Genes Based on the Immune Microenvironment in Patients With Thymoma.Front Genet. 2022 Feb 11;13:668696. doi: 10.3389/fgene.2022.668696. eCollection 2022. Front Genet. 2022. PMID: 35222524 Free PMC article.
-
Hematological response of topotecan in tumor-bearing rats: modeling of the time course of different cellular populations.Pharm Res. 2004 Apr;21(4):567-73. doi: 10.1023/b:pham.0000022402.00699.5c. Pharm Res. 2004. PMID: 15139512
-
Paraneoplastic Leukemoid Reaction in Gastroesophageal Junction Adenocarcinoma: A Case Report.Am J Case Rep. 2020 Jan 31;21:e919596. doi: 10.12659/AJCR.919596. Am J Case Rep. 2020. PMID: 32001665 Free PMC article.
-
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy.Clin Transl Radiat Oncol. 2018 Jul 6;12:8-15. doi: 10.1016/j.ctro.2018.07.002. eCollection 2018 Aug. Clin Transl Radiat Oncol. 2018. PMID: 30073209 Free PMC article.
-
Paraneoplastic leukemoid syndrome in squamous cell carcinoma of the forearm.BMJ Case Rep. 2023 Jan 12;16(1):e249970. doi: 10.1136/bcr-2022-249970. BMJ Case Rep. 2023. PMID: 36634990 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources